SynthesisBMJ open2026
Prognostic factors for pain intensity and function in individuals with temporomandibular disorders (TMDs): a systematic review and meta-analysis.
Synthesis in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the prognosis and prognostic factors associated with pain intensity and function in individuals with temporomandibular disorders (TMDs). Secondary objectives included identifying prognostic factors related to symptom progression, subsequent treatment needs and psychosocial outcomes.
designSystematic review with meta-analysis. DATA SOURCES: Medline, Dentistry and Oral Sciences Source, SportDiscus and CINAHL (EBSCOhost) were searched up to September 2025. ELIGIBILITY CRITERIA: Prospective longitudinal studies examining prognostic factors for pain intensity or functional outcomes in adults with TMD, with a minimum follow-up of 3 months. DATA EXTRACTION AND SYNTHESIS: Two independent reviewers screened titles and abstracts and assessed full texts for eligibility. Data were extracted in duplicate using a standardised protocol that included study characteristics, prognostic factors and outcomes. Risk of bias was assessed using the QUIPS (Quality in Prognosis Studies) tool, and the certainty of evidence was graded using a modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Meta-analyses were performed with random-effects models, reporting ORs and 95% CIs. Heterogeneity was evaluated using
resultsNine prospective studies met the inclusion criteria; eight were included in quantitative analyses (n=4282) and one large cohort was synthesised narratively (n=94 769), for a total of 99 051 participants. After standardising definitions, 56 candidate factors were analysed. In adjusted models for pain, pain provoked by movement or palpation was associated with a worse course (eg, joint pain with sound: OR=2.10, 95% CI 1.39 to 3.18; muscle pain during movement: OR=2.10, 95% CI 1.33 to 3.31), while shorter pain duration (OR=0.25, 95% CI 0.09 to 0.70) and greater pain-free mouth opening (OR=0.60, 95% CI 0.40 to 0.90) were protective. For the function outcome, pain intensity was associated with poorer outcomes (OR=1.39, 95% CI 1.14 to 1.69), whereas age, sex, depression, somatisation, disability days and self-efficacy showed no consistent associations.
conclusionsIn adults with TMD, pain provoked by movement or palpation and higher pain intensity were consistently associated with less favourable prognoses. Conversely, shorter pain duration and greater pain-free opening were associated with better outcomes. These associations are non-causal and based on low to very low certainty evidence amid methodological heterogeneity. While they may inform risk stratification, they should not guide treatment decisions without confirmatory longitudinal studies using standardised outcomes and improved control of confounders. PROSPERO REGISTRATION NUMBER: CRD42024557159.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.